S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: The truth about war with China (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden, McCarthy reach final deal to prevent default, now must sell to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
15 A.I. Trading Opportunities a Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: The truth about war with China (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden, McCarthy reach final deal to prevent default, now must sell to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
15 A.I. Trading Opportunities a Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: The truth about war with China (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden, McCarthy reach final deal to prevent default, now must sell to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
15 A.I. Trading Opportunities a Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
BREAKING: The truth about war with China (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
Biden, McCarthy reach final deal to prevent default, now must sell to Congress
15 A.I. Trading Opportunities a Day (Ad)
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
15 A.I. Trading Opportunities a Day (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Turkey's Erdogan wins another term as president, extends rule into 3rd decade
OTCMKTS:GALNF

Galenica (GALNF) Stock Forecast, Price & News

C$75.25
0.00 (0.00%)
(As of 05/12/2023)
Compare
Today's Range
C$75.25
C$75.25
50-Day Range
C$75.25
C$75.25
52-Week Range
C$75.25
C$75.25
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GALNF stock logo

About Galenica (OTCMKTS:GALNF) Stock

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Receive GALNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galenica and its competitors with MarketBeat's FREE daily newsletter.

GALNF Stock News Headlines

See More Headlines
Receive GALNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galenica and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Distribution
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GALNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Marc Werner (Age 56)
    Chief Exec. Officer
    Comp: $1.34M
  • Mr. Felix Burkhard (Age 57)
    CFO & Head of Investor Relations
  • Ms. Barbara Walchli
    Gen. Counsel & Gen. Sec.
  • Ms. Christina Hertig
    Head of Corp. Communications
  • Dr. Thomas F. Szuran (Age 56)
    Chief Products & Marketing Officer
  • Ms. Marianne Ellenberger (Age 60)
    Head of HR
  • Dr. Jörg Kneubühler (Age 63)
    Advisor
  • Mr. Daniele Madonna (Age 46)
    Chief Healthcare Officer
  • Mr. Andreas Koch (Age 52)
    Head of Wholesale & Logistics
  • Ms. Virginie Pache Jeschka (Age 44)
    Chief Pharmacies Officer













GALNF Stock - Frequently Asked Questions

Should I buy or sell Galenica stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Galenica in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GALNF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GALNF, but not buy additional shares or sell existing shares.
View GALNF analyst ratings
or view top-rated stocks.

How have GALNF shares performed in 2023?

Galenica's stock was trading at C$75.25 at the beginning of 2023. Since then, GALNF stock has increased by 0.0% and is now trading at C$75.25.
View the best growth stocks for 2023 here
.

What is Galenica's stock symbol?

Galenica trades on the OTCMKTS under the ticker symbol "GALNF."

How do I buy shares of Galenica?

Shares of GALNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Galenica's stock price today?

One share of GALNF stock can currently be purchased for approximately C$75.25.

How can I contact Galenica?

The official website for the company is www.galenica.com. The company can be reached via phone at 41 58 852 81 11.

This page (OTCMKTS:GALNF) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -